trending Market Intelligence /marketintelligence/en/news-insights/trending/IN1MNWqY2NKXe7ml_i_fQQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Neovasc closes $5M stock offering to fund heart device development

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Neovasc closes $5M stock offering to fund heart device development

Neovasc Inc. closed an underwritten public offering of 11,111,111 common shares, priced at 45 cents each.

The Richmond, British Columbia-based medical-device maker raised $5 million in gross proceeds that will be used to develop and commercialize its heart devices Neovasc Reducer and Tiara.

Funds from the offering will also be used for general corporate and working capital purposes.

H.C. Wainwright & Co. served as the sole book-running manager for the offering.